|  | Non-thallium scan group | |||
---|---|---|---|---|---|
 | Thallium scan group (n = 113) | Unmatched cohort (n = 731) | p value | Matched cohort (n = 339) | p value |
Age, mean ± SD, years | 79.8 ± 8.3 | 74.7 ± 11.3 | < 0.001 | 79.9 ± 8.3 | 0.901 |
Sex, n (%) | Â | Â | 0.590 | Â | 0.908 |
 Male | 37 (32.7) | 221 (30.2) |  | 109 (32.2) |  |
 Female | 76 (67.3) | 510 (69.8) |  | 230 (67.8) |  |
Body mass index, mean ± SD, kg/m2 | 22.6 ± 3.5 | 22.7 ± 4.1 | 0.774 | 22.5 ± 3.9 | 0.980 |
ASA grade, n (%) |  |  | < 0.001 |  | 0.010 |
 1 | 0 (0.0) | 11 (1.5) |  | 2 (0.6) |  |
 2 | 5 (4.4) | 185 (25.3) |  | 57 (16.8) |  |
 3 | 106 (93.8) | 523 (71.5) |  | 270 (79.6) |  |
 4 | 1 (0.9) | 10 (1.4) |  | 8 (2.4) |  |
Delay until surgery, mean ± SD, days | 7.0 ± 12.4 | 2.4 ± 3.3 | < 0.001 | 3.7 ± 4.2 | < 0.001 |
Delay until surgery > 2 days, n (%) | 110 (97.3) | 352 (48.2) | < 0.001 | 127 (37.5) | < 0.001 |
Preoperative comorbidities, n (%) | |||||
 Ischemic heart disease | 25 (22.1) | 56 (7.7) | < 0.001 | 47 (13.9) | 0.038 |
 CHF | 6 (5.3) | 27 (3.7) | 0.431 | 20 (5.9) | 0.816 |
 Valvular heart disease | 11 (9.7) | 18 (2.5) | 0.001 | 17 (5.0) | 0.071 |
 CVA | 11 (9.7) | 76 (10.4) | 0.829 | 34 (10.0) | 0.928 |
 Diabetes | 44 (38.9) | 216 (29.5) | 0.044 | 123 (36.3) | 0.613 |
 COPD | 13 (11.5) | 53 (7.3) | 0.117 | 31 (9.1) | 0.464 |
 RA | 1 (0.9) | 14 (1.9) | 0.440 | 3 (0.9) | 1.000 |
 Liver disease | 2 (1.8) | 37 (5.1) | 0.121 | 7 (2.1) | 1.000 |
 Renal disease | 14 (12.4) | 59 (8.1) | 0.129 | 37 (10.9) | 0.668 |
 Cancer | 4 (3.5) | 48 (6.6) | 0.213 | 12 (3.5) | 1.000 |
Anesthesia type, n (%) | Â | Â | 0.071 | Â | 0.597 |
 General | 94 (83.2) | 651 (89.1) |  | 289 (85.3) |  |
 Regional | 19 (16.8) | 80 (10.9) |  | 50 (14.7) |  |
Cemented stem, n (%) | 65 (57.5) | 297 (40.6) | < 0.001 | 199 (58.7) | 0.826 |
Time in surgical theater, mean ± SD, min | 125.9 ± 36.3 | 132.3 ± 44.5 | 0.142 | 125.5 ± 33.8 | 0.930 |